Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer
Clinical trial NCT03801304 · COMPLETED
Trial details
- NCT number
- NCT03801304
- Sponsor
- University Hospital, Brest
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2021-01-04
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.